Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
A cross-sectional study, performed at a routine human immunodeficiency virus (HIV)/AIDS clinic in Cameroon that uses the World Health Organization public health approach, showed low rates of virological failure and drug resistance at 12 and 24 months after initiation of antiretroviral therapy. Importantly, the cross-sectional study also showed that the World Health Organization recommendation for second-line treatment would be effective in almost all patients with HIV drug resistance mutations.
Kouanfack
Charles
C
Central Hospital and 2Virology Laboratory, Centre de Recherche du Service Santé des Armées (CRESAR)/Institut de Recherche de Médicine et sur les Plantes Médicinales (IMPM)/Institut de Recherche pour le Développement (IRD), Yaoundé, Cameroon.
Montavon
Celine
C
Laurent
Christian
C
Aghokeng
Avelin
A
Kenfack
Alain
A
Bourgeois
Anke
A
Koulla-Shiro
Sinata
S
Mpoudi-Ngole
Eitel
E
Peeters
Martine
M
Delaporte
Eric
E